2016
DOI: 10.1016/j.carres.2016.04.012
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical characterization of the novel α-1, 3-galactosyltransferase WclR from Escherichia coli O3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 27 publications
0
8
0
Order By: Relevance
“…Another important variable may be the exposure to different types and levels of microorganisms of the healthy microbiota. Several bacterial pathogens able to synthetize α1,3-Gal such as Escherichia coli (34), Streptococcus pneumonia (33) Salmonella (16) or parasites may also contribute to immunization in the childhood or adulthood in specific pathological contexts. Moreover, inflammatory bowel diseases and gastrointestinal infections are particularly associated with adherent-invasive Escherichia coli (37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
“…Another important variable may be the exposure to different types and levels of microorganisms of the healthy microbiota. Several bacterial pathogens able to synthetize α1,3-Gal such as Escherichia coli (34), Streptococcus pneumonia (33) Salmonella (16) or parasites may also contribute to immunization in the childhood or adulthood in specific pathological contexts. Moreover, inflammatory bowel diseases and gastrointestinal infections are particularly associated with adherent-invasive Escherichia coli (37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
“…The synthesis of the glycan Galα1-3Galβ1-4GlcNAc-R (α-Gal) by the enzyme α-1,3-galactosyltransferase occurs in bacteria [10][11][12][13], fungi [14][15][16], and noncatarrhine mammals [17], but prokaryotic and eukaryotic α-1,3-galactosyltransferase genes and proteins share little structural homology [18][19][20]. Humans, old world monkeys and apes evolved with the inability to synthesize α-Gal, which resulted in the capacity to produce anti-α-Gal IgM/IgG antibodies with a protective activity against pathogenic viruses (e.g., HIV), bacteria (e.g., Mycobacterium) and parasites (e.g., Plasmodium), containing this modification on membrane proteins [21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…The natural IgM/IgG antibodies against α-Gal are produced in response to gut microbiota bacteria having this modification [21,24]. Several bacteria of the family Enterobacteriaceae such as Klebsiella pneumonia [10], Escherichia coli [11,12] and Salmonella spp. [13,24] are known to express α1,3-galactosyltransferase genes, and to synthetize α-Gal, in the human gut microbiome [24].…”
Section: Introductionmentioning
confidence: 99%
“…Surprisingly, recent results revealed that double-KO pigs for the genes ggta1 and a3galT 2 have α-Gal-residual activity 13 . Fungi and bacteria also express α1-3 galt genes encoding for enzymes that synthetize α-Gal, but prokaryotic and eukaryotic α1-3 GALT proteins share little structural homology 1 , 14 16 . These results suggested that (i) α1-3 GALTs activity is redundant in animal tissues, (ii) all the enzymes responsible for α-Gal synthesis in animals have not been discovered, and (iii) α1-3 GALT enzymes have evolved independently in prokaryotic and eukaryotic organisms.…”
Section: Introductionmentioning
confidence: 99%